Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00211679
Status:
UNKNOWN
Last Update Posted:
2005-09-21
First Post:
2005-09-13
Brief Title:
Intra-articularInjection of Botulinum Toxin Type
Sponsor:
Minneapolis Veterans Affairs Medical Center
Organization:
Minneapolis Veterans Affairs Medical Center
Study Overview
Official Title:
Intra-articularInjection of Botulinum Toxin Type a for the Treatment of Chronic Knee Pain A Randomized Placebo Controlled Double Blind Study
Status:
UNKNOWN
Status Verified Date:
2005-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether intra-articular injection of botulinum toxin is effective in the treatment of chronic knee paindue to arthritis
Detailed Description:
Chronic knee pain unresponsive to oral medications and intra-articular corticosteroids and viscosupplements is an important treatment problem especially for the young very old and those with complex medical problems that preclude joint reconstructive surgery We hypothesized that intra-articular botulinum toxin could provide important joint pain relief in these patients This is a prospective double blined placebo controlled 6month trial with an open label extension phase when pain returns to baseline levels re-injection with 100units of botulinum toxin and 6 months followup thereafter
Comparisons Intra-articular injection of bootulinum toxin type a will be compared to intra-articular injection of lidocaine the saline
Comparisons Intra-articular injection of bootulinum toxin type a will be compared to intra-articular injection of lidocaine the saline
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None